Can-Fite BioPharma Files 6-K, Incorporates Press Release
Ticker: CANF · Form: 6-K · Filed: Apr 17, 2025 · CIK: 1536196
| Field | Detail |
|---|---|
| Company | Can-Fite Biopharma LTD. (CANF) |
| Form Type | 6-K |
| Filed Date | Apr 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, sec, registration-statement
TL;DR
Can-Fite BioPharma filed a 6-K on 4/17/25, incorporating a press release into its S-8 and F-3 filings.
AI Summary
On April 17, 2025, Can-Fite BioPharma Ltd. filed a Form 6-K, reporting information for the month of April 2025. This filing incorporates by reference a press release (Exhibit 99.1) into its existing Registration Statements on Form S-8 and Form F-3. The company's principal executive offices are located at 26 Ben Gurion Street, Ramat Gan, Israel.
Why It Matters
This filing serves to update SEC filings with information from a press release, potentially impacting investors' understanding of the company's current activities and disclosures.
Risk Assessment
Risk Level: low — This filing is primarily procedural, incorporating previously issued information into SEC filings, and does not appear to contain new material financial or operational developments.
Key Players & Entities
- Can-Fite BioPharma Ltd. (company) — Registrant
- April 17, 2025 (date) — Filing Date
- 26 Ben Gurion Street, Ramat Gan, Israel (location) — Principal Executive Offices
- Form S-8 (document) — Incorporated Registration Statement
- Form F-3 (document) — Incorporated Registration Statement
FAQ
What is the purpose of this Form 6-K filing by Can-Fite BioPharma Ltd.?
The Form 6-K is a Report of Foreign Private Issuer filed for the month of April 2025, and it incorporates by reference a press release (Exhibit 99.1) into the registrant's Registration Statements on Form S-8 and Form F-3.
When was this Form 6-K filed with the SEC?
The Form 6-K was filed on April 17, 2025.
What are the principal executive offices of Can-Fite BioPharma Ltd.?
The principal executive offices are located at 26 Ben Gurion Street, Ramat Gan, 5257346, Israel.
Which SEC Registration Statements are being updated by this filing?
This filing incorporates information into Registration Statements on Form S-8 (File No. 333-227753, 333-271384 and 333-278525) and Form F-3 (File Nos. 333-236064, 333-276000, 333-274316, 333-281872, and 333-262055).
Does Can-Fite BioPharma Ltd. file annual reports under Form 20-F or Form 40-F?
Can-Fite BioPharma Ltd. indicates that it files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 17, 2025 regarding Can-Fite BioPharma Ltd. (CANF).